From: Radiopharmaceuticals: navigating the frontier of precision medicine and therapeutic innovation
Application | Radiopharmaceutical role | Description | References |
---|---|---|---|
Cancer therapy | Radiolabelling of nanoparticles for targeted imaging and therapy | - Targeted delivery of chemotherapeutic agents to tumors - Enhanced permeability and retention effect utilization - Personalized treatment with controlled drug release - Combination therapy for synergistic effects | [68] |
Imaging-guided therapies | Incorporation of radiotracers for real-time monitoring | - Simultaneous imaging and therapy for real-time monitoring - Image-guided drug release using external triggers - Theranostic agents for precise diagnosis and treatment | [69] |
Neurological disorders | Radiopharmaceutical-guided nanoparticle delivery | - Blood–brain barrier crossing for central nervous system drug delivery - Targeted therapy for neurodegenerative diseases | [70] |
Inflammatory conditions | Radiolabelled nanoparticles for tracking and therapy | - Targeted delivery of anti-inflammatory agents - Nanoparticle-based immune modulation | [71] |
Cardiovascular applications | Radiolabelling to assess nanoparticle distribution | - Drug delivery to diseased blood vessels - Reduction of systemic side effects | [72] |
Gene delivery | Radiopharmaceutical labeling for tracking gene delivery | - Nucleic acid delivery for gene therapy - Targeted gene editing and modulation | [73] |
Personalized medicine | Radiotracer-guided customization of drug delivery | - Tailored drug delivery based on patient-specific markers - Customized treatment regimens | [74] |
Minimizing side effects | Radiolabelling for tracking nanoparticle biodistribution | - Localized drug release to reduce systemic toxicity - Controlled and sustained drug delivery | [75] |
Combination therapies | Radiopharmaceutical tracking of combination therapy | - Simultaneous delivery of multiple therapeutic agents - Synergistic effects for enhanced efficacy | [76] |
Regenerative medicine | Radiolabelling for monitoring tissue repair | - Controlled delivery of growth factors for tissue repair - Stem cell therapy augmentation with targeted drugs | [77] |